Inflammatory Bowel Disease
1 drug5,253 FAERS reportsMedDRA PT
GET
/api/v1/reaction/inflammatory-bowel-diseaseReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D015212
Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
Source: U.S. National Library of Medicine — MeSH (Inflammatory Bowel Diseases)
Drugs reporting Inflammatory Bowel Disease (1)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Isotretinoin5,25311%
Literature
Recent PubMed references pinned to Inflammatory Bowel Diseases as a MeSH major topic. About the reaction term itself — not about any specific drug.
- MODULATING OXIDATIVE STRESS AND INFLAMMATION: SODIUM BUTYRATE'S THERAPEUTIC PROMISE IN EXPERIMENTAL COLITIS.Arquivos de gastroenterologia · 2026 · Murshed NMF, Swaroopa S, Al-Awadhi SSA, et al.PMID 42207086DOI 10.1590/S0004-2803.24612025-129
- THE IMPACT OF OBESITY ON THE CLINICAL COURSE OF INFLAMMATORY BOWEL DISEASE.Arquivos de gastroenterologia · 2026 · Borsato ROR, Chebli JMF, Ribeiro TCDR, et al.PMID 42207082DOI 10.1590/S0004-2803.24612025-093
- ASSOCIATED FACTORS AND CLINICAL ASPECTS OF COLECTOMY IN PATIENTS WITH ULCERATIVE COLITIS - EXPERIENCE OF A BRAZILIAN SOUTHEASTERN COHORT.Arquivos de gastroenterologia · 2026 · Ferreira SDC, Parra RS, Perdoná GDSC, et al.PMID 42207073DOI 10.1590/S0004-2803.24612025-096
- GENERATIVE AI TOWARDS A COMPARATIVE ANALYSIS OF HOSPITALIZATION RATES AMONG PATIENTS WITH ULCERATIVE COLITIS TREATED WITH INFLIXIMAB, VEDOLIZUMAB, AND TOFACITINIB IN THE PUBLIC HEALTHCARE SYSTEM IN BRAZIL: A NATIONWIDE STUDY.Arquivos de gastroenterologia · 2026 · Valverde DA, Quaresma AB, Villamil MPG, et al.PMID 42207071DOI 10.1590/S0004-2803.24612025-066
- [Ubiquitination modification of NLRP3 inflammasome and its role in inflammatory bowel disease].Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology · 2026 · Xu Y, Li YPMID 42206713
- Research Progress on the Mechanism of Ginsenoside Rg1 in Inflammatory Bowel Disease.Journal of immunology research · 2026 · Liang D, Yang S, Jing D, et al.PMID 42206644DOI 10.1155/jimr/9743121
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.